The Journal for Nurse Practitioners
Volume 6, Issue 7 , Pages 534-539 , July 2010

Pneumococcal Vaccination and Specific Polysaccharide Antibody Deficiency Syndrome

  • Shannon Munro Cohen

      Affiliations

    • Shannon Munro Cohen, PhD, APRN, BC, FNP, is a nurse practitioner working in an asthma, allergy, and immunology practice.

References 

  1. National Foundation for Infectious Diseases  . Facts about pneumococcal disease . Available at: http://www.nfid.org/pneumococcal/consumers_factsheet.html Accessed 10/20/09.
  2. Niessen L , Hove A , Hilderink H , Weber M , Mulholland K , Ezzati M . Comparative impact assessment of child pneumonia interventions . Bull World Health Organ . 2009;87:472–480
  3. Centers for Disease Control and Prevention  . Epidemiology and prevention of vaccine preventable diseases: pneumococcal disease . In:  Atkinson W ,  Wolfe S ,  Hamborsky J ,  McIntyre L editor. 11th edition. Washington, DC: Public Health Foundation; 2009;p. 217–229
  4. Grijalva CG . Recognizing pneumonia burden through prevention . Vaccine . 2009;27(S3):C6–C8
  5. Pletz MW , Maus U , Krug N , Welte T , Lode H . Pneumococcal vaccines: mechanisms of action, impact on epidemiology, and adaption of the species . Int J Antimicrob Agents . 2008;32(3):199–206
  6. Campos D . CDC recommendations expand vaccine recommendations . J Fam Pract . 2009;58(3):146–148
  7. Kyaw MH , Rose CE , Fry AM , et al.   The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults . J Infect Dis . 2005;192:377–386
  8. Rubins JB , Janoff EN . Pneumococcal disease in the elderly: what is preventing vaccine efficacy? . Drugs Aging . 2001;18(5):305–311
  9. Centers for Disease Control and Prevention  . Recommended adult immunization schedule–United States, 2009 . MMWR Morb Mortal Wkly Rep . 2009;57(53):Q1–Q4
  10. Paris K , Sorensen MD . Assessment and clinical interpretation of polysaccharide antibody responses . Ann Allergy Asthma Immunol . 2007;99(5):462–464
  11. American Academy of Pediatrics  . Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis . Pediatrics . 2000;106(2):362–366
  12. Bernatoniene J , Finn A . Advances in pneumococcal vaccines: advantages for infants and children . Drugs . 2005;65(2):229–255
  13. Murdoch DR . Raising the profile of pneumococcal disease . Intern Med J . 2008;38:381–383
  14. Centers for Disease Control and Prevention  . Emergence of antimicrobial resistant serotype 19A Streptococcus pneumoniae–Massachusetts, 2001–2006 . MMWR Morb Mortal Wkly Rep . 2009;56(41):1077–1080
  15. Scott P , Huss A . Efficacy of pneumococcal polysaccharide vaccine . Can Med Assoc J . 2009;180(11):1134–1135
  16. Hsieh Y , Lee W , Shao P , Chang L , Huang L . The transforming streptococcus pneumoniae in the 21st century . Chang Gung Med J . 2008;31(2):117–124
  17. Schenkein JG , Park S , Nahm MH . Pneumococcal vaccination in older adults induces antibodies with low opsonic capacity and reduced antibody potency . Vaccine . 2008;26(43):5521–5526
  18. Centers for Disease Control and Prevention  . Some common misconceptions about vaccination and how to respond to them . Available at: http://www.cdc.gov/vaccines/vac-gen/6mishome.htm Accessed 11/25/09.
  19. McNeil JC , Hulten KG , Mason EO , Kaplan SL . Serotype 19A is the most common Streptococcus pneumoniae isolate in children with chronic sinusitis . Pediatr Infect Dis J . 2009;28(9):766–768
  20. Cheng YK , Decker PA , O'Byrne MM , Weiler CR . Clinical and laboratory characteristics of 75 patients with specific polysaccharide antibody deficiency syndrome . Ann Allergy Asthma Immunol . 2006;97:306–311
  21. Anderson VL . Uncovering a pediatric immunodeficiency . J Nurse Pract . 2006;2(3):186–193
  22. Chin T . IgA and IgG subclass deficiencies. EMedicine from WebMD . Available at: http://emedicine.medscape.com/article/885348-overview 2009; Accessed Oct 29, 2009.
  23. Aldrich N , Keyser CM . CDC says immunizations reduce deaths from influenza and pneumococcal disease among older adults . Available at: http://www.cdc.gov/vaccines/vpd-vac/flu/downloads/influ-pneu-disease-2008.txt Accessed Oct 29, 2009.
  24. Johnson DR , Nichol KL , Lipczynski K . Barriers to adult immunization . Am J Med . 2008;121(7):S28–S35
  25. Nowalk MP , Zimmerman RK , Shen S , Jewell IK , Hyg MS , Raymund M . Barriers to pneumococcal and influenza vaccination in older community dwelling adults (2000-2001) . J Am Geriatr Soc . 2004;52:25–30
  26. Jackson LA , Benson P , Sneller VP , et al.   Safety of revaccination with pneumococcal polysaccharide vaccine . JAMA . 1999;281(3):280–281
  27. Rodriguez R , Dyrer PD . Safety of pneumococcal revaccination . J Gen Intern Med . 1995;10(9):511–512
  28. Yousef E , Mannan S . Systemic reaction to pneumococcal vaccine: how common in pediatrics? . JAMA . 1999;281(3):243–248

 In compliance with national ethical guidelines, the author reports no relationships with business or industry that would pose a conflict of interest.

PII: S1555-4155(10)00036-X

doi: 10.1016/j.nurpra.2010.01.015

The Journal for Nurse Practitioners
Volume 6, Issue 7 , Pages 534-539 , July 2010

Article Tools